ImmuPharma plc (GB:IMM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
ImmuPharma PLC, a specialist biopharmaceutical company, has announced the granting of share options to two of its directors. Lisa Baderoon received 3 million share options, while Laurence Reilly was granted 2 million, both with an exercise price of 2.24 pence per share. These options are valid for 10 years and will vest after three years from the issue date.
For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.
